B-lymphocyte stimulator (BLYS) in rheumatoid arthritis: Clinical, biological and prognostic relevance

被引：0
|
作者：
Fabris, M
Tolusso, B
Gremese, E
Tomietto, P
Sacco, S
Quartuccio, L
Ferraccioli, G
机构：
[1] Univ Udine, Div Rheumatol, DPMSC, I-33100 Udine, Italy
[2] Univ Cattolica Sacro Cuore, Dept Rheumatol, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Synovial B-lymphocyte reduction predicts clinical response in rheumatoid arthritis patients treated with rituximab
    Burgoyne, C. H.
    Dass, S.
    Vital, E. M.
    English, A.
    Coulthard, L. R.
    Reece, R. J.
    Rawstron, A. C.
    Ponchel, F.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A59 - A59
  • [22] The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
    Cancro, Michael P.
    D'Cruz, David P.
    Khamashta, Munther A.
    JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05): : 1066 - 1073
  • [23] Belimumab (BmAb), a novel fully human monoclonal antibody to B-lymphocyte stimulator (BLyS), selectively modulates B-cell sub-populations and immunoglobulins in a heterogeneous rheumatoid arthritis subject population.
    Stohl, W
    Chatham, W
    Weisman, M
    Furie, R
    Weinstein, A
    Mishra, N
    Chevrier, M
    Fernandez, V
    Migone, TS
    Freimuth, W
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S444 - S444
  • [24] B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders
    Edwards, JCW
    Leandro, MJ
    Cambridge, G
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 824 - 828
  • [25] An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA
    Tian, Yu
    Zhu, Yan-feng
    Wu, Zhen
    Feng, Jian-nan
    Li, Yan
    Shen, Bei-fen
    Sun, Jian
    BIOTECHNOLOGY LETTERS, 2013, 35 (04) : 523 - 528
  • [26] B-LYMPHOCYTE ALLOANTIGENS IN STUDY OF GENETIC BASIS OF RHEUMATOID-ARTHRITIS
    PANAYI, GS
    WOOLEY, PH
    ANNALS OF THE RHEUMATIC DISEASES, 1977, 36 (04) : 365 - 368
  • [27] An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA
    Yu Tian
    Yan-feng Zhu
    Zhen Wu
    Jian-nan Feng
    Yan Li
    Bei-fen Shen
    Jian Sun
    Biotechnology Letters, 2013, 35 : 523 - 528
  • [28] B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection
    Fabris, M.
    Quartuccio, L.
    Sacco, S.
    De Marchi, G.
    Pozzato, G.
    Mazzaro, C.
    Ferraccioli, G.
    Migone, T. S.
    De Vita, S.
    RHEUMATOLOGY, 2007, 46 (01) : 37 - 43
  • [29] B-Lymphocyte Stimulator and A Proliferation Inducing Ligand In Lupus Nephritis: Low Serum Levels Of BLyS Predict Treatment Response
    Parodis, Ioannis
    Zickert, Agneta
    Svenungsson, Elisabet
    Malmstrom, Vivianne
    Gunnarsson, Iva
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1197 - S1197
  • [30] A role for B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
    Zhang, J
    Wang, Z
    Chatham, W
    Carter, R
    Kimberly, R
    Zhou, T
    FASEB JOURNAL, 2001, 15 (04): : A325 - A325
12345